Results 161 to 170 of about 4,077,222 (303)

Obesity is always a clinically relevant chronic disease. [PDF]

Eat Weight Disord
Donini LM, Ballesteros-Pomar MD, Batsis JA, Boirie Y, Cappellari GG, Poggiogalle E, Barazzoni R.   +6 more
europepmc   +1 more source

How Rebate Bans, Discriminatory MLS Listing Policies, and Minimum Service Requirements Can Reduce Price Competition for Real Estate Brokerage Services and Why It Matters [PDF]

Institutional characteristics of a typical residential real estate transaction may create a causal link between commission rate reductions and service degradation. Such a link mitigates agents’ incentive to compete on commission rates.
Matthew Magura
core  

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Correction to "Enhanced Antibacterial Efficacy of Copper Single-Atom Catalysts on Two-Dimensional Boron Nitride Platform". [PDF]

ACS Nano
Li W, Maldonado-Lopez D, Zhao Y, Wang C, Gao J, Sun B, Bai Y, Sun L, Zhao M, He H, Lou J, Yu Q, Zhang X, Pandey VK, Kang F, Terrones M, Mendoza-Cortes JL, Lei Y.   +17 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Segment-targeted peroral endoscopic myotomy for recurrent diffuse esophageal spasm with giant diverticula. [PDF]

Endoscopy
Li LD, He DL, Zhong YS.
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Acute physical activity supports inhibitory control in primary school children: a randomised cross-over trial. [PDF]

Sci Rep
Watson E, Burgess PW, Metcalf I, Hamer M, Ronca F.   +4 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025. [PDF]

Orphanet J Rare Dis
Graessner H, Ripp S, Pereira AM, Schaefer F, Mathijssen I, Blay JY, Mulders PFA, Evangelista T, Ligtenberg MJL, Wilde AAM, Ladenstein R, Lohse AW, Mosca M, Swart JF, Hernández F, Fenaux P, Dollfus H, Verloes A, Wagner T, Bodemer C, Wijnen R, Scarpa M, Jondeau G, Tumienė B, Gallina S, Arzimanoglou A, Sangiorgi L.   +26 more
europepmc   +1 more source